Stem Cell-Based Toxicity Screening

  title={Stem Cell-Based Toxicity Screening},
  author={Sebastian Greenhough and David C. Hay},
  journal={Pharmaceutical Medicine},
Preclinical cell-based toxicity screening is an essential stage in the drug development process. Current technology is based on immortalized cell lines, rodent cells and primary human hepatocytes, all of which suffer from shortcomings. Cell lines and rodent cells have limited relevance to human physiology, while primary human cells remain a scarce and variable resource. These systems are inadequate, as evidenced by the high levels of compound attrition in the clinical trial and postmarketing… 
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology.
The hepatocyte is the major functional cell type found in the liver and the advantages offered by pluripotent stem cell-derived hepatocytes are discussed.
Application of Stem Cells and iPS Cells in Toxicology
Fertilization of an oocyte by a spermatozoid, or in general terms, fertilization of the female gamete by the male gamete results in the genesis of the basic unit in the development of an organism,
Development of a Convenient In Vivo Hepatotoxin Assay Using a Transgenic Zebrafish Line with Liver-Specific DsRed Expression
The LiPan transgenic fry provide a rapid and convenient in vivo hepatotoxicity assay that should be applicable to high-throughput hepatot toxicity test in drug screening as well as in biomonitoring environmental toxicants.
Consequences of non-alcoholic fatty liver disease on drug-induced hepatocytoxicity.
The hypothesised effect of steatosis on drug toxicity has been confirmed and Steatosis may enhance drug toxicity through changing cellular oxidative state and activating the apoptotic pathway.
Hepatic cells and enzymes reactions in wistar rats exposed to x-ray film processing chemicals
Medical images play significant roles in the diagnosis and management of patients. In developing countries darkroom radiography is practiced and involves chemical processing of films using chemical
Rules relating hepatotoxicity with structural attributes of drugs
The relationship between molecular structures of drugs and their hepatotoxicity was studied by characterizing their structure in a new way and using formal concept analysis, a mathematical technique
Nutraceutical values of hot water infusions of moringa leaf (Moringa oleifera) and licorice root (Glycyrrhiza glabra) and their effects on liver biomarkers in Wistar rats
Globally, there is an increasing need to consume health promoting foods and beverages as alternatives to synthetic drugs. Moringa leaf (Moringa oleifera) and Licorice root (Glycyrrhiza glabra) have


Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.
Embryonic stem cell-derived hepatocytes expressed liver-specific genes, but not genes representing other lineages, secreted functional human liver- specific proteins similar to those of primary human hepatocytes, and showed human hepatocyte cytochrome P450 metabolic activity.
Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells
It is demonstrated that mouse iPS cells retain full potential for fetal liver development and a procedure is described that facilitates the efficient generation of highly differentiated human hepatocyte‐like cells fromiPS cells that display key liver functions and can integrate into the hepatic parenchyma in vivo.
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.
These patient-derived hepatocytes demonstrate that it is possible to model diseases whose phenotypes are caused by pathological dysregulation of key processes within adult cells, and a simple and effective platform for hepatocyte generation from patient-specific human iPS cells.
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
This study demonstrates the direct induction of functional hepatocyte-like (iHep) cells from mouse tail-tip fibroblasts by transduction of Gata4, Hnf1α and Foxa3, and inactivation of p19Arf and provides a novel strategy to generate functional hepatocytes-like cells for the purpose of liver engineering and regenerative medicine.
Disease-Specific Induced Pluripotent Stem Cells
In vitro evaluation of potential hepatotoxicity induced by drugs.
Omic (cytomic, metabonomic, proteomic and toxicogemic) approaches help defining patterns of hepatotoxicity for early identification of potential adverse effects of the drug to the liver and the development of robust in vitro-based multiparametric screening assays covering a wider spectrum of key effects will heighten the predictive capacity for human hepatot toxicity and accelerate the drug development process.
Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development
A robust and efficient method to differentiate pluripotent stem cells into hepatic cells, which exhibit characteristics of human hepatocytes are reported, which should facilitate the development of clinical grade hepatocytes for transplantation and for research on drug discovery.
Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs
The cryopreserved HepaRG cell system is shown to be quantitatively comparable to human hepatocytes for prediction of clearance of drug cytochrome P450 substrates and to represent a promising alternative in vitro tool.